EGFR c.2582T>A ;(p.L861Q)

Variant ID: 7-55259524-T-A

NM_005228.3(EGFR):c.2582T>A;(p.L861Q)

This variant was identified in 1473 publications

View GRCh38 version.




Publications:


Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence.

Translational Lung Cancer Research
Yuan, Chongze C; Yao, Xingxin X; Dai, Pengfei P; Zhao, Yue Y; Sun, Yihua Y
Publication Date: 2023-05-31

Variant appearance in text: EGFR: L861Q
PubMed Link: 37323170
Variant Present in the following documents:
  • Main text
  • tlcr-12-05-985.pdf
View BVdb publication page



Characterization of p38α autophosphorylation inhibitors that target the non-canonical activation pathway.

Nature Communications
González, Lorena L; Díaz, Lucía L; Pous, Joan J; Baginski, Blazej B; Duran-Corbera, Anna A; Scarpa, Margherita M; Brun-Heath, Isabelle I; Igea, Ana A; Martin-Malpartida, Pau P; Ruiz, Lidia L; Pallara, Chiara C; Esguerra, Mauricio M; Colizzi, Francesco F; Mayor-Ruiz, Cristina C; Biondi, Ricardo M RM; Soliva, Robert R; Macias, Maria J MJ; Orozco, Modesto M; Nebreda, Angel R AR
Publication Date: 2023-06-12

Variant appearance in text: EGFR: L861Q
PubMed Link: 37308482
Variant Present in the following documents:
  • 41467_2023_39051_MOESM3_ESM.xlsx, sheet 5
View BVdb publication page



Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.

Medcomm
Sang, Na N; Zhong, Xi X; Gou, Kun K; Liu, Huan H; Xu, Jing J; Zhou, Yang Y; Zhou, Xia X; Liu, Yuanzhi Y; Chen, Zhiqian Z; Zhou, Yue Y; Li, Yan Y; Tao, Lei L; Su, Na N; Zhou, Lingyun L; Qiu, Jiahao J; Yang, Xinyu X; Zuo, Zeping Z; Fu, Li L; Zhang, Jingyao J; Li, Dan D; Li, Cong C; Sun, Qingxiang Q; Lei, Jian J; Li, Rui R; Yang, Shengyong S; Cen, Xiaobo X; Zhao, Yinglan Y
Publication Date: 2023-06

Variant appearance in text: EGFR: L861Q
PubMed Link: 37250145
Variant Present in the following documents:
  • MCO2-4-e269-s001.pdf
View BVdb publication page



Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need.

International Journal Of Molecular Sciences
Pretelli, Giulia G; Spagnolo, Calogera Claudia CC; Ciappina, Giuliana G; Santarpia, Mariacarmela M; Pasello, Giulia G
Publication Date: 2023-05-17

Variant appearance in text: EGFR: L861Q
PubMed Link: 37240224
Variant Present in the following documents:
  • Main text
  • ijms-24-08878.pdf
View BVdb publication page



The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology.

Journal Of The Advanced Practitioner In Oncology
Moore, Donald C DC; Guinigundo, Andrew S AS
Publication Date: 2023-04

Variant appearance in text: EGFR: L861Q
PubMed Link: 37206905
Variant Present in the following documents:
  • Main text
  • jadpro-14-15.pdf
View BVdb publication page



Updating the Targeted Therapy Paradigm for Patients With Metastatic NSCLC.

Journal Of The Advanced Practitioner In Oncology
Florez Duma, Narjust N; Mcdonald, Stephanie S
Publication Date: 2023-04

Variant appearance in text: EGFR: L861Q
PubMed Link: 37197732
Variant Present in the following documents:
  • Main text
  • jadpro-14-241.pdf
View BVdb publication page



Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based IdyllaTM System.

Cancer Control : Journal Of The Moffitt Cancer Center
Boustany, Youssra Y; Laraqui, Abdelilah A; El Zaitouni, Sara S; Ghaouti, Merieme M; Benzekri, Asmae A; Kettani, Fouad F; Oukabli, Mohammed M; Ennibi, Khalid K; Belkadi, Bouchra B; Sekhsokh, Yassine Y
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37196225
Variant Present in the following documents:
  • Main text
  • 10.1177_10732748231177538.pdf
View BVdb publication page



Current therapy and development of therapeutic agents for lung cancer.

Cell Insight
Wang, Zilai Z; Kim, Jiyeon J; Zhang, Pin P; Galvan Achi, Jazmin M JM; Jiang, Yuwei Y; Rong, Lijun L
Publication Date: 2022-04

Variant appearance in text: EGFR: L861Q
PubMed Link: 37193130
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



CRAC (Clinical Relevance of Alterations in Cancer): a Knowledge Base for the Selection of Molecularly Matched Therapy for Solid Tumors.

Sovremennye Tekhnologii V Meditsine
Lebedeva, A A AA; Kavun, A I AI; Veselovsky, E M EM; Mileyko, V A VA; Ivanov, M V MV
Publication Date: 2022

Variant appearance in text: EGFR: L861Q
PubMed Link: 37181287
Variant Present in the following documents:
  • Main text
  • STM-14-6-02.pdf
View BVdb publication page



Demographics and Clinicopathologic Profile of Pulmonary Sarcomatoid Carcinoma with Survival Analysis and Genomic Landscape.

Cancers
Ullah, Asad A; Ahmed, Asim A; Yasinzai, Abdul Qahar Khan AQK; Lee, Kue Tylor KT; Khan, Israr I; Asif, Bina B; Khan, Imran I; Tareen, Bisma B; Kakar, Kaleemullah K; Andam, Gul G; Heneidi, Saleh S; Khan, Jaffar J; Khan, Hina H; Karki, Nabin R NR; Del Rivero, Jaydira J; Karim, Nagla Abdel NA
Publication Date: 2023-04-26

Variant appearance in text: EGFR: L861Q
PubMed Link: 37173936
Variant Present in the following documents:
  • Main text
  • cancers-15-02469.pdf
View BVdb publication page



Pan-cancer whole-genome comparison of primary and metastatic solid tumours.

Nature
Martínez-Jiménez, Francisco F; Movasati, Ali A; Brunner, Sascha Remy SR; Nguyen, Luan L; Priestley, Peter P; Cuppen, Edwin E; Van Hoeck, Arne A
Publication Date: 2023-05-10

Variant appearance in text: EGFR: L861Q
PubMed Link: 37165194
Variant Present in the following documents:
  • 41586_2023_6054_MOESM3_ESM.pdf
  • 41586_2023_6054_MOESM1_ESM.pdf
  • 41586_2023_6054_MOESM12_ESM.xlsx, sheet 5
View BVdb publication page



A real-world study of Afatinib plus ramucirumab in treatment-naïve, EGFR-mutated, non-small cell lung cancer.

Bmc Cancer
Huang, Chun-Yao CY; Huang, Hui-Li HL; Lan, Chou-Chin CC; Huang, Yi-Chih YC; Wu, Yao-Kuang YK
Publication Date: 2023-05-08

Variant appearance in text: EGFR: L861Q
PubMed Link: 37158884
Variant Present in the following documents:
  • Main text
  • 12885_2023_Article_10909.pdf
View BVdb publication page



P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomas.

Acta Neuropathologica Communications
Vij, Meenakshi M; Cho, Benjamin B BB; Yokoda, Raquel T RT; Rashidipour, Omid O; Umphlett, Melissa M; Richardson, Timothy E TE; Tsankova, Nadejda M NM
Publication Date: 2023-05-03

Variant appearance in text: EGFR: L861Q
PubMed Link: 37138345
Variant Present in the following documents:
  • 40478_2023_1573_MOESM1_ESM.xlsx, sheet 1
View BVdb publication page



Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.

The Oncologist
Wang, Chunsheng C; Zhao, Kewei K; Hu, Shanliang S; Dong, Wei W; Gong, Yan Y; Xie, Conghua C
Publication Date: 2023-04-28

Variant appearance in text: EGFR: L861Q
PubMed Link: 37116899
Variant Present in the following documents:
  • Main text
  • oyad111.pdf
View BVdb publication page



Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.

Jama Network Open
Roberts, Thomas J TJ; Kehl, Kenneth L KL; Brooks, Gabriel A GA; Sholl, Lynette L; Wright, Alexi A AA; Landrum, Mary Beth MB; Keating, Nancy L NL
Publication Date: 2023-04-03

Variant appearance in text: EGFR: L861Q
PubMed Link: 37115543
Variant Present in the following documents:
  • jamanetwopen-e2310809-s001.pdf
View BVdb publication page



Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice.

Frontiers In Pharmacology
Song, Xiaotong X; Cao, Luchang L; Ni, Baoyi B; Wang, Jia J; Qin, Xiaoyan X; Sun, Xiaoyue X; Xu, Bowen B; Wang, Xinmiao X; Li, Jie J
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37089959
Variant Present in the following documents:
  • Main text
  • fphar-14-1090500.pdf
View BVdb publication page



Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective.

Acs Chemical Neuroscience
Ong, Han Wee HW; Liang, Yi Y; Richardson, William W; Lowry, Emily R ER; Wells, Carrow I CI; Chen, Xiangrong X; Silvestre, Margaux M; Dempster, Kelvin K; Silvaroli, Josie A JA; Smith, Jeffery L JL; Wichterle, Hynek H; Pabla, Navjot S NS; Ultanir, Sila K SK; Bullock, Alex N AN; Drewry, David H DH; Axtman, Alison D AD
Publication Date: 2023-04-21

Variant appearance in text: EGFR: L861Q
PubMed Link: 37084253
Variant Present in the following documents:
  • cn3c00135_si_001.pdf
View BVdb publication page



Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer.

Technology In Cancer Research & Treatment
Yu, Limeng L; Wang, Ruilin R; Zhao, Yuhua Y; Wu, Yingxi Y; Wang, Lili L; Chen, Haiyang H; He, Zhen Z; Wang, Qiming Q; Wu, Yufeng Y
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37078129
Variant Present in the following documents:
  • Main text
  • 10.1177_15330338231168466.pdf
View BVdb publication page



The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis.

Disease Markers
Li, Duo D; Li, Meng M; Li, Hong H; Shi, Puyu P; Chen, Mingwei M; Yang, Tian T
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37077340
Variant Present in the following documents:
  • DM2023-5272125.pdf
View BVdb publication page



Ultra-rapid Idylla™ EGFR mutation screening followed by next-generation sequencing: An integrated solution to molecular diagnosis of non-small cell lung cancer.

Frontiers In Oncology
Qiu, Tian T; Zhang, Fanshuang F; Zheng, Bo B; Feng, Zitong Z; Li, Weihua W; Zeng, Hua H; Chu, Lixia L; Ying, Jianming J
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37064089
Variant Present in the following documents:
  • Main text
  • fonc-13-1064487.pdf
View BVdb publication page



[A Real-world Study on the Expression Characteristics of PD-L1 in Patients 
with Advanced EGFR Positive NSCLC and Its Relationship with the 
Therapeutic Efficacy of EGFR-TKIs].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Chen, Ran R; Gao, Xiang X; Xu, Fudong F; Zhang, Shucai S; Ma, Li L; Hu, Bo B
Publication Date: 2023-03-20

Variant appearance in text: EGFR: L861Q
PubMed Link: 37035884
Variant Present in the following documents:
  • zgfazz-26-3-217.pdf
View BVdb publication page



Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma.

Frontiers In Immunology
Koh, Young Wha YW; Park, Bumhee B; Jung, Se Hee SH; Han, Jae-Ho JH; Haam, Seokjin S; Lee, Hyun Woo HW
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 37033978
Variant Present in the following documents:
  • Main text
  • fimmu-14-1137880.pdf
View BVdb publication page



Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones.

Journal Of Medicinal Chemistry
Harnden, Alice C AC; Davis, Owen A OA; Box, Gary M GM; Hayes, Angela A; Johnson, Louise D LD; Henley, Alan T AT; de Haven Brandon, Alexis K AK; Valenti, Melanie M; Cheung, Kwai-Ming J KJ; Brennan, Alfie A; Huckvale, Rosemary R; Pierrat, Olivier A OA; Talbot, Rachel R; Bright, Michael D MD; Akpinar, Hafize Aysin HA; Miller, Daniel S J DSJ; Tarantino, Dalia D; Gowan, Sharon S; de Klerk, Selby S; McAndrew, Peter Craig PC; Le Bihan, Yann-Vaï YV; Meniconi, Mirco M; Burke, Rosemary R; Kirkin, Vladimir V; van Montfort, Rob L M RLM; Raynaud, Florence I FI; Rossanese, Olivia W OW; Bellenie, Benjamin R BR; Hoelder, Swen S
Publication Date: 2023-04-07

Variant appearance in text: EGFR: L861Q
PubMed Link: 37026591
Variant Present in the following documents:
  • jm3c00155_si_002.xlsx, sheet 2
View BVdb publication page



Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors.

Cancer Research Communications
Sun, Boyang B; Qiu, Tian T; Zeng, Xiaoling X; Duan, Jianchun J; Bai, Hua H; Xu, Jiachen J; Li, Jin J; Li, Junling J; Hao, Xuezhi X; Liu, Yutao Y; Lin, Lin L; Wang, Hongyu H; Zhang, Xin X; Zhong, Jia J; Wang, Jie J; Ying, Jianming J; Wang, Zhijie Z
Publication Date: 2023-04

Variant appearance in text: EGFR: L861Q
PubMed Link: 37025355
Variant Present in the following documents:
View BVdb publication page



Osimertinib combined with bevacizumab as the first-line treatment in non-small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations.

Thoracic Cancer
Zhang, Ling L; You, Yunhong Y; Liu, Xueli X; Liu, Fengjuan F; Nie, Keke K; Ji, Youxin Y
Publication Date: 2023-04-05

Variant appearance in text: EGFR: L861Q
PubMed Link: 37016906
Variant Present in the following documents:
  • Main text
  • TCA-14-1355.pdf
View BVdb publication page



Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues.

Nature Communications
Abelin, Jennifer G JG; Bergstrom, Erik J EJ; Rivera, Keith D KD; Taylor, Hannah B HB; Klaeger, Susan S; Xu, Charles C; Verzani, Eva K EK; Jackson White, C C; Woldemichael, Hilina B HB; Virshup, Maya M; Olive, Meagan E ME; Maynard, Myranda M; Vartany, Stephanie A SA; Allen, Joseph D JD; Phulphagar, Kshiti K; Harry Kane, M M; Rachimi, Suzanna S; Mani, D R DR; Gillette, Michael A MA; Satpathy, Shankha S; Clauser, Karl R KR; Udeshi, Namrata D ND; Carr, Steven A SA
Publication Date: 2023-04-03

Variant appearance in text: EGFR: L861Q
PubMed Link: 37012232
Variant Present in the following documents:
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 2
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 3
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 2
  • 41467_2023_37547_MOESM10_ESM.xlsx, sheet 4
  • 41467_2023_37547_MOESM12_ESM.xlsx, sheet 3
View BVdb publication page



Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies.

Thoracic Cancer
Meng, Ying Y; Bai, Rilan R; Cui, Jiuwei J
Publication Date: 2023-04-02

Variant appearance in text: EGFR: L861Q
PubMed Link: 37005552
Variant Present in the following documents:
  • Main text
  • TCA-14-1121.pdf
View BVdb publication page



Plasma ctDNA increases tissue NGS-based detection of therapeutically targetable mutations in lung cancers.

Bmc Cancer
Xie, Jianjiang J; Yao, Weishen W; Chen, Lingxiu L; Zhu, Wenjun W; Liu, Qiang Q; Geng, Geng G; Fang, Jing J; Zhao, Yang Y; Xiao, Li L; Huang, Zhenhua Z; Zhao, Jing J
Publication Date: 2023-03-31

Variant appearance in text: EGFR: Leu861Gln
PubMed Link: 37004022
Variant Present in the following documents:
  • Main text
  • 12885_2023_10674_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



NSCLC in the Era of Targeted and Immunotherapy: What Every Pulmonologist Must Know.

Diagnostics (Basel, Switzerland)
Mitchell, Carley L CL; Zhang, Annie L AL; Bruno, Debora S DS; Almeida, Francisco A FA
Publication Date: 2023-03-15

Variant appearance in text: EGFR: L861Q
PubMed Link: 36980426
Variant Present in the following documents:
  • diagnostics-13-01117.pdf
View BVdb publication page



Deep Annotation of Donated Chemical Probes (DCP) in Organotypic Human Liver Cultures and Patient-Derived Organoids from Tumor and Normal Colorectum.

Acs Chemical Biology
Tredup, Claudia C; Ndreshkjana, Benardina B; Schneider, Natalie S NS; Tjaden, Amelie A; Kemas, Aurino M AM; Youhanna, Sonia S; Lauschke, Volker M VM; Berger, Benedict-Tilman BT; Krämer, Andreas A; Berger, Lena M LM; Röhm, Sandra S; Knapp, Stefan S; Farin, Henner F HF; Müller, Susanne S
Publication Date: 2023-03-21

Variant appearance in text: EGFR: L861Q
PubMed Link: 36944371
Variant Present in the following documents:
  • cb2c00877_si_004.xlsx, sheet 1
View BVdb publication page



Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.

Jama Network Open
Chi, Sang Ah SA; Yu, Hyeyeon H; Choi, Yoon-La YL; Park, Sehhoon S; Sun, Jong-Mu JM; Lee, Se-Hoon SH; Ahn, Jin Seok JS; Ahn, Myung-Ju MJ; Choi, Dae-Ho DH; Kim, Kyunga K; Jung, Hyun Ae HA; Park, Keunchil K
Publication Date: 2023-03-01

Variant appearance in text: EGFR: L861Q
PubMed Link: 36929402
Variant Present in the following documents:
  • Main text
View BVdb publication page



Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors.

Bmc Cancer
Huang, Chun-Ta CT; Lin, Chih-An CA; Su, Te-Jen TJ; Yang, Ching-Yao CY; Tsai, Tzu-Hsiu TH; Hsu, Chia-Lin CL; Liao, Wei-Yu WY; Chen, Kuan-Yu KY; Ho, Chao-Chi CC; Yu, Chong-Jen CJ
Publication Date: 2023-03-13

Variant appearance in text: EGFR: L861Q
PubMed Link: 36915101
Variant Present in the following documents:
  • Main text
  • 12885_2023_Article_10698.pdf
View BVdb publication page



Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC.

Frontiers In Oncology
He, Ping P; Liu, Jie J; Xu, Qingyuan Q; Ma, Huaijun H; Niu, Beifang B; Huang, Gang G; Wu, Wei W
Publication Date: 2023

Variant appearance in text: EGFR: 2582T>A; L861Q; rs121913444
PubMed Link: 36910641
Variant Present in the following documents:
  • DataSheet_1.xlsx, sheet 8
View BVdb publication page



A single-arm, multicenter, phase II trial of osimertinib in patients with epidermal growth factor receptor exon 18 G719X, exon 20 S768I, or exon 21 L861Q mutations.

Esmo Open
Villaruz, L C LC; Wang, X X; Bertino, E M EM; Gu, L L; Antonia, S J SJ; Burns, T F TF; Clarke, J J; Crawford, J J; Evans, T L TL; Friedland, D M DM; Otterson, G A GA; Ready, N E NE; Wozniak, A J AJ; Stinchcombe, T E TE
Publication Date: 2023-03-09

Variant appearance in text: EGFR: L861Q
PubMed Link: 36905787
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays.

Cancers
Barthelemy, David D; Lescuyer, Gaelle G; Geiguer, Florence F; Grolleau, Emmanuel E; Gauthier, Arnaud A; Balandier, Julie J; Raffin, Margaux M; Bardel, Claire C; Bouyssounouse, Bruno B; Rodriguez-Lafrasse, Claire C; Couraud, Sébastien S; Wozny, Anne-Sophie AS; Payen, Léa L
Publication Date: 2023-03-03

Variant appearance in text: EGFR: L861Q
PubMed Link: 36900363
Variant Present in the following documents:
  • Main text
  • cancers-15-01574.pdf
View BVdb publication page



Investigation of the anti-tumor mechanism of tirabrutinib, a highly selective Bruton's tyrosine kinase inhibitor, by phosphoproteomics and transcriptomics.

Plos One
Kozaki, Ryohei R; Yasuhiro, Tomoko T; Kato, Hikaru H; Murai, Jun J; Hotta, Shingo S; Ariza, Yuko Y; Sakai, Shunsuke S; Fujikawa, Ryu R; Yoshida, Takao T
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 36897912
Variant Present in the following documents:
  • pone.0282166.s009.xlsx, sheet 1
View BVdb publication page



Healthcare coverage affects survival of EGFR-mutant Thai lung cancer patients.

Frontiers In Oncology
Khiewngam, Khantong K; Oranratnachai, Songporn S; Kamprerasart, Kaettipong K; Kunakorntham, Patratorn P; Sanvarinda, Pimtip P; Trachu, Narumol N; Pimsa, Pongput P; Wiwitkeyoonwong, Jirapath J; Thamrongjirapat, Thanaporn T; Dejthevaporn, Thitiya T; Sirachainan, Ekaphop E; Reungwetwattana, Thanyanan T
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 36895484
Variant Present in the following documents:
  • Main text
  • fonc-13-1047644.pdf
View BVdb publication page



Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer.

Frontiers In Pharmacology
Wang, Man M; Zhu, Lijie L; Yang, Xiaoxu X; Li, Jiahui J; Liu, Yu'e Y; Tang, Ying Y
Publication Date: 2023

Variant appearance in text: EGFR: L861Q
PubMed Link: 36874015
Variant Present in the following documents:
  • Main text
  • fphar-14-1132158.pdf
View BVdb publication page



Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2.

Signal Transduction And Targeted Therapy
Wang, Penglei P; Jia, Xuechao X; Lu, Bingbing B; Huang, Han H; Liu, Jialin J; Liu, Xuejiao X; Wu, Qiong Q; Hu, Yamei Y; Li, Pan P; Wei, Huifang H; Liu, Tingting T; Zhao, Dengyun D; Zhang, Lingwei L; Tian, Xueli X; Jiang, Yanan Y; Qiao, Yan Y; Nie, Wenna W; Ma, Xinli X; Bai, Ruihua R; Peng, Cong C; Dong, Zigang Z; Liu, Kangdong K
Publication Date: 2023-03-06

Variant appearance in text: EGFR: L861Q
PubMed Link: 36872366
Variant Present in the following documents:
  • 41392_2023_1329_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



[Initial Treatment of Aumolertinib in Combination with Bevacizumab for Advanced NSCLC with Primary EGFR T790M Mutation: A Report of Three Cases and Literature Review].

Zhongguo Fei Ai Za Zhi = Chinese Journal Of Lung Cancer
Yang, Xue X; Meng, Fanlu F; Zhong, Diansheng D
Publication Date: 2023-02-20

Variant appearance in text: EGFR: L861Q
PubMed Link: 36872054
Variant Present in the following documents:
  • Main text
  • zgfazz-26-158.pdf
View BVdb publication page